These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 811653)

  • 21. Dansyl chloride labeling of Pseudomonas aeruginosa treated with pyocin R1: change in permeability of the cell envelope.
    Uratani Y
    J Bacteriol; 1982 Feb; 149(2):523-8. PubMed ID: 6799489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Colicin M-Type Bacteriocin from Pseudomonas aeruginosa Targeting the HxuC Heme Receptor Requires a Novel Immunity Partner.
    Ghequire MGK; Öztürk B
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. F-Type Pyocins Are Diverse Noncontractile Phage Tail-Like Weapons for Killing
    Saha S; Ojobor CD; Li ASC; Mackinnon E; North OI; Bondy-Denomy J; Lam JS; Ensminger AW; Maxwell KL; Davidson AR
    J Bacteriol; 2023 Jun; 205(6):e0002923. PubMed ID: 37260386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of active transport and macromolecular synthesis by pyocin 103 in Neisseria gonorrhoeae.
    Stein DC; Clark VL; Young FE
    Sex Transm Dis; 1983; 10(1):7-13. PubMed ID: 6189200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of three bacteriocins of Bacteroides fragilis.
    Riley TV; Mee BJ
    Microbios; 1985; 43(173):115-33. PubMed ID: 3903439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of bacteriocin production by clinical Pseudomonas aeruginosa isolates and their potential as therapeutic agents.
    Charkhian H; Soleimannezhadbari E; Bodaqlouei A; Lotfollahi L; Lotfi H; Yousefi N; Shojadel E; Gholinejad Z
    Microb Cell Fact; 2024 Jun; 23(1):175. PubMed ID: 38872163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relations between antibiotic resistance and pyocin P3 resistance in Pseudomonas aeruginosa mutants].
    García-Quintana HG; Wilckens R
    Zentralbl Veterinarmed B; 1983 Apr; 30(3):169-74. PubMed ID: 6408850
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile].
    García-Quintana HG; Polette M; Ríos J
    Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Petrocheilou-Malliara K; Koukoubanis N; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):199. PubMed ID: 3151341
    [No Abstract]   [Full Text] [Related]  

  • 30. Pyocin sensitivity of Neisseria gonorrhoeae and its feasibility as an epidemiological tool.
    Sidberry HD; Sadoff JC
    Infect Immun; 1977 Feb; 15(2):628-37. PubMed ID: 403141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pore-forming pyocin S5 utilizes the FptA ferripyochelin receptor to kill Pseudomonas aeruginosa.
    Elfarash A; Dingemans J; Ye L; Hassan AA; Craggs M; Reimmann C; Thomas MS; Cornelis P
    Microbiology (Reading); 2014 Feb; 160(Pt 2):261-269. PubMed ID: 24217175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of F-type pyocins of Pseudomonas aeruginosa.
    Kuroda K; Kageyama M
    J Biochem; 1981 Jun; 89(6):1721-36. PubMed ID: 6793563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting the adsorption of a pyocin by cells of Pseudomonas aeruginosa.
    Stewart DJ; Young H
    Microbios; 1971 Jan; 3(9):15-22. PubMed ID: 5005819
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on a receptor for pyocin in a R mutant of Salmonella minnesota.
    Krämer J; Bradenbrink G; Brandis H
    Zentralbl Bakteriol Orig A; 1979 Jun; 243(4):457-64. PubMed ID: 113953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyocin S5 Import into Pseudomonas aeruginosa Reveals a Generic Mode of Bacteriocin Transport.
    Behrens HM; Lowe ED; Gault J; Housden NG; Kaminska R; Weber TM; Thompson CMA; Mislin GLA; Schalk IJ; Walker D; Robinson CV; Kleanthous C
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple photometric method for determination of the activity of pyrocin R1.
    Kumazaki T; Ishii S
    J Biochem; 1982 Mar; 91(3):817-23. PubMed ID: 6804454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of environment on sensitivity of Neisseria gonorrhoeae to Pseudomonas aeruginosa bacteriocins.
    Stein DC; Hebeler BH; Young FE
    Infect Immun; 1980 Aug; 29(2):507-11. PubMed ID: 6783533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro pyocin activity of Pseudomonas aeruginosa strains pretreated with antibiotics.
    Al-Ani FY; Al-Shibib AS
    Folia Microbiol (Praha); 1985; 30(4):349-52. PubMed ID: 3928466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the biosynthesis and morphogenesis of R-type pyocins of Pseudomonas aeruginosa. IV. Quantitative estimation of the rates of synthesis of pyocin R subunit proteins.
    Shinomiya T
    J Biochem; 1974 Nov; 76(5):1083-94. PubMed ID: 4217793
    [No Abstract]   [Full Text] [Related]  

  • 40. Bacteriocin-mediated competition in cystic fibrosis lung infections.
    Ghoul M; West SA; Johansen HK; Molin S; Harrison OB; Maiden MC; Jelsbak L; Bruce JB; Griffin AS
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26311664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.